Correlation between vitamin D binding protein expression and angiographic-proven coronary artery disease

Coronary Artery Disease

Volumn 23, Issue 7, 2012, Pages 426-431

  Rocchiccioli, Silvia ^a   G Andreassi, Maria ^a   Cecchettini, Antonella ^a,b   Carpeggiani, Clara ^a   L'Abbate, Antonio ^c   Citti, Lorenzo ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

coronary artery disease; myocardial infarction; plasma proteomics; vitamin D binding protein

Indexed keywords

VITAMIN D BINDING PROTEIN;

ADULT; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HUMAN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SURVIVOR;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PRINCIPAL COMPONENT ANALYSIS; PROTEOMICS; SEVERITY OF ILLNESS INDEX; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VITAMIN D-BINDING PROTEIN;

EID: 84867506170     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328358781c     Document Type: Article

References (23)

1. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al. Heart disease and stroke statistics 2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117:e25-e146.
2. Parekh R. Proteomics and molecular medicine. Nat Biotechnol 1999; 17:19-20.
3. Schiffer E, Mischak H, Novak J. High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS. Proteomics 2006; 6:5615-5627.
4. Anderson NL, Anderson NG. The human plasma proteome history, character, and diagnostic prospects. Mol Cell Proteomics 2002; 1: 845-867.
5. Oldgren J, Wallantin L, Grip L, Linder R, Norgaard BL, Siegbahn A. Myocardial damage, inflammation and thrombin inhibition in unstable coronary artery disease. Eur Heart J 2003; 24:86-93.
6. Newby LK, Goldmann BU, Ohman EM. Troponin: An important prognostic marker and risk-stratification tool in non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 2003; 6S:31S-41S.
7. Collet JP, Montalescot G, Vicaut E, Ankri A, Walylo F, Lesty C, et al. Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality. Circulation 2003; 108: 391-394.
8. Májek P, ReicheltováZ, Suttnar J, MalýM, Oravec M, PecánkováK, et al. Plasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1. J Transl Med 2011; 9:84-90.
9. Neubert H, Bonnert TP, Rumpel K, Hunt BT, Henle ES, James IT. Label-free detection of differential protein expression by LC/MALDI mass spectrometry. J Proteome Res 2008; 7:2270-2279.
10. Rocchiccioli S, Citti L, Boccardi C, Ucciferri N, Tedeschi L, Lande C, et al. A gel-free approach in vascular smooth muscle cell proteome: Perspectives for a better insight into activation. Proteome Sci 2010; 8:15-24.
11. Citti L, Rocchiccioli S, Mercatanti A, Boccardi C, Parodi O. Method for separating the constituents of a complex mixture of proteins to submit to proteomic analysis. Patent number: PCT/IB2009006989; 2009.
12. Conley CA. Leiomodin and tropomodulin in smooth muscle. Am J Physiol Cell Physiol 2001; 280:C1645-C1656.
13. Vercellotti GM, Balla G, Balla J, Nath K, Eaton JW, Jacob HS. Heme and the vasculature: An oxidative hazard that induces antioxidant defenses in the endothelium. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 207-213.
14. Dardè VM, De la Cuesta F, Dones FG, Alvarez-Llamas G, Banderas MG, Vivanco F. Analysis of the plasma proteome associated with acute coronary syndrome: Does a permanent protein signature exist in the plasma of ACS patients? J Proteome Res 2010; 9:4420-4432.
15. Afshar-Kharghan V, Matijevic-Aleksic N, Ahn C, Boerwinkle E,Wu KK, Lopez JA. The variable number of tandem repeat polymorphism of platelet glycoprotein Ib alpha and risk of coronary heart disease. Blood 2004; 103:963-965.
16. White P, Cooke N. The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 2000; 11: 320-327.
17. Cooke NE, Haddad JG. Vitamin D binding protein (Gc-globulin). Endocr Rev 1989; 10:294-307.
18. Namamoto N, Homma S, Millman I. Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages. J Immunol 1991; 147: 273-280.
19. Meier U, Gressner O, Lammert F, Gressner AM. Gc-globulin: Roles in response to injury. Clin Chem 2006; 52:1247-1253.
20. Gasparri C, Curcio A, Torella D, Gaspari M, Celi V, Salituri F, et al. Proteomics reveals high levels of vitamin D binding protein in myocardial infarction. Front Biosci 2010; 2:796-804.
21. Schellenberg D, Pare PD, Weir TD, Spinelli JJ, Walker BA, Sandford AJ. Vitamin D binding protein variants and the risk of COPD. Am J Respir Crit Care Med 1998; 157:957-961.
22. Berhane BT, Zong C, Liem DA, Huang A, Le S, Edmondson RD, et al. Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project pilot phase. Proteomics 2005; 5: 3520-3530.
23. Mateos-Ca'ceres PJ, Garci'a-Méndez A, López FarréA, Macaya C, Nu'nez A, Go'mez J, et al. Proteomics analysis of plasma from patients during an acute coronary syndrome. J Am Coll Cardiol 2004; 44:1578-1583.